Digital Library/Neuropsychopharmacology – 5th Generation of Progress
Published in 2002, the Fifth Edition synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. Nine sections focus on specific groups of disorders–disorders of development; schizophrenia and related disorders; anxiety and stress disorders; affective disorders; Alzheimer’s and other dementias; substance use disorders; impulsive and compulsive disorders; movement disorders and paroxysmal disorders; and chronobiology and sleep disorders. Each group of disorders is discussed in detail, including clinical course, genetics, neurobiology, neuroimaging, and current and emerging therapeutics. Four sections cover neurotransmitter and signal transduction, emerging methods in molecular biology and genetics, emerging imaging technologies and their psychiatric applications, and drug discovery and evaluation.
Neuropsychopharmacology: The Fifth Generation of Progress Editors:
Kenneth L. Davis
Joseph T. Coyle
Lippincott, Williams, & Wilkins, Philadelphia, Pennsylvania, 2002
Could susceptibility to near all early onset psychiatric disorders be predicted by a three-factor model: dopamine, externalizing, early life stress? https://bit.ly/3aC0OpG @npp_journal #MentalHealth #stress
The prefrontal cortex is an incredibly diverse swath of tissue. See how its various subregions may differentially contribute to stability and variability in thought and conscious experience in this new piece https://go.nature.com/2YOxQAo @KalinaChristoff @RCarhartHarris @npp_journal